Abstract:OBJECTIVE: We analyzed the impact of potent anti-hypertension or anti-thrombotic therapy after PCI in patients with coronary heart disease complicated with hypertension, whilst to reflect the prognosis by testing P-selectin. PATIENTS AND METHODS: A total of 177 patients with coronary heart disease (CHD) complicated with hypertension was continuously enrolled in this study and randomly divided into traditional anti-hypertension group (group A: 130/80 mm Hg <= BP <= 140/90 mm Hg; anti-hypertensive drugs: beta blockers and angiotensin converting enzyme inhibitor, n=84) and potent anti- hypertension group (group B: BP < 130/80 mm Hg; dosage and frequency in group B > group A, n=93). This study was approved by the Ethics Committee of Shaoxing People's Hospital. Signed written informed consents were obtained from all participants before the study. Patients who need a stent placed (CAG shows narrowed vascular diameter =75%) have to continuously be followed-up for one year. Standard anti-hypertension (fluctuation of BP < 5 mm Hg measured for 3 successive days) was detected respectively at admission and inpatient. The blood pressure, low-density lipoprotein cholesterin (LDL-C), high-sensitivity C-reactive protein (hs-CRP) and P-selectin levels were tested 1 month and 1 year after discharge; the time of adverse events (AEs) was also recorded. RESULTS: There were no statistical differences between the occurrence times of AEs between group A and B (p=0.946). The P-selectin [(83+/-21) vs. (69+/-16) mu g/L, p=0.038], systolic pressure [(134+/-8) vs. (119+/-13) mm Hg, p< 0.001] and diastolic pressure [(85+/-6) vs. (70+/-5) mm Hg] in group A were higher (p=0.001) than those of group B. Compared with P-selectin =50.00 mu g/L, the median survival time (> 12 vs. 10 months,.2 =3.621, p=0.047) of P-selectin < 50.00 mu g/L was longer. By comparing P-selectin in different SBP grading (< 120 mm Hg, 120130 mm Hg, 130-140 mm Hg), the difference was statistically significant (.2=12.912, p=0.002). CONCLUSIONS: Potent anti-hypertension may influence the occurrence time of AEs after PCI in patients with coronary heart disease complicated hypertension. P-selectin can be a sensitive indicator. SBP has an apparent "J-curve effect" and an appropriate anti-hypertensive scope (120-130 mm Hg).

Effects of Percutaneous Transluminal Coronary Angioplasty on Serum Soluble Intercellular Adhesion Molecule-1 and P-selectin Levels

Changes of Plasma P-selectin、 Thrombomodulin、 Plasminogen Activator Inhibitor-1 of Coronary Artery Disease Patients Before and after PTCA

Impacts of Atherosclerotic Plaque Composition and Platelet Aggregation on Serum Cardiactroponin T Elevation after Percutaneous Coronary Interventions

The Study of the Effect of PTCA on P-selectin,Plasminogen Activator In hibitor-1 and Mg2+ in Peripheral Blood

The Change and Clinical Significance of Serum Tumor Necrosis Factor-Α、interleukin-6 and Interleukin-8 after Cutting Balloon Angioplasty and Stent Implantation

Release of endothelin 1 and angiotensin II induced by percutaneous transluminal coronary angioplasty

The Serum Levels of High Sensitivity C-reactive Protein and Cardiac Events after Percutaneous Coronary Intervention

Temporal Changes in Circulating P-selectin, Plasminogen Activator Inhibitor-1, Magnesium, and Creatine Kinase after Percutaneous Coronary Intervention

Effects of Diltiazem on Platelet Activation and Cytosolic Calcium During Percutaneous Transluminal Coronary Angioplasty.

Association of postprocedural neutrophil count and myocardial perfusion in ST elevation myocardial infarction patients after percutaneous coronary intervention

Effects of liposomal prostaglandin E1 on fibrinolytic system in peri-percutaneous coronary interventional in acute coronary syndrome

[Changes of Plasma High-Sensitive C-reactive Protein and Monocyte Chemotactic Factor-1 Following Percutaneous Coronary Interventional Procedures in Patients with Coronary Artery Disease].

Study on the heart release kinetics of endothelin after percutaneous transluminal coronary angioplasty(PTCA)

Effect of percutaneous intervention on adrenomedullin and tumor necrosis factor in the coronary circulation]

Changes of the Serum Level of C-reactive Protein after Coronary Angioplasty

Changes of Serum Soluble Intercellular Adhesion Molecule-1 and P-selectin in Coronary Heart Disease

Long-term Outcome Analysis of Patients Underwent Percutaneous Coronary Intervention with Prior Ischemic Stroke

Percutaneous coronary intervention results in increases of lipoprotein(a) and oxidized lipoprotein(a) in patients with acute coronary syndrome

Elevated High Sensitive C-reactive Protein and Apelin Levels after Percutaneous Coronary Intervention and Drug-Eluting Stent Implantation

Percutaneous Transluminal Coronary Angioplasty. Its Success Rate and Affecting Factors.

Impacts of serum P-selectin on blood pressure control after PCI in patients with coronary heart disease complicated with hypertension.